Skip to main content

MoneyWorks4Me

Aarey Drugs & Pharmaceuticals informs about quarterly statement on investor complaints

08 Oct 2016 Evaluate

Aarey Drugs & Pharmaceuticals has informed regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Redington 327.50
Adani Enterprises 2735.00
Amrapali Industries 33.57
Maxgrow India 172.35
Rashi Peripheral 738.20
View more..